Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Bürgisser

Showing results (1-10 of 47) with videos related to

Pageof 5
Sort By:
Journal of Receptor Research|January 1, 1983
Model testing in radioligand/receptor interaction by Monte Carlo simulationE Bürgisser
Journal of Receptor Research|January 1, 1984
Methods for the determination of the specific radioactivity of radioligandsE Bürgisser
Helvetica Chimica Acta|April 21, 1976
One-step purification of bovine adrenal glucose-6-phosphate dehydrogenase by affinity chromatographyE Bürgisser, J L Fauchère
Journal of Receptor Research|January 1, 1983
Human lymphocytes as a model for beta-adrenergic receptors in clinical investigationR Landmann, E Bürgisser, F R Bühler
Molecular Pharmacology|May 1, 1981
Alternative explanation for the apparent "two-step" binding kinetics of high-affinity racemic antagonist radioligandsE Bürgisser, R J Lefkowitz, A DeLean
Journal of Cyclic Nucleotide and Protein Phosphorylation Research|January 1, 1985
Inhibition of [3H]Gpp(NH)p release from human platelet membranes by GDPL M Banta, F R Bühler, E Bürgisser
Molecular Pharmacology|December 1, 1985
Activation of human blood platelets by arginine-vasopressin. Role of bivalent cationsA Pletscher, P Erne, E Bürgisser, et al.
European Journal of Pharmacology|April 6, 1984
Inappropriate correction for radioactive decay in fully iodinated adrenergic radioligandsV M Doyle, F R Bühler, E Bürgisser
Naunyn-Schmiedeberg'S Archives of Pharmacology|April 1, 1984
Ca2+ as messenger of 5HT2-receptor stimulation in human blood plateletsH Affolter, P Erne, E Bürgisser, et al.
Hypertension (Dallas, Tex. : 1979)|August 1, 1986
Enhanced platelet cyclic AMP response to prostaglandin E1 in essential hypertensionT J Resink, E Bürgisser, F R Bühler
Pageof 5

Showing results (1-10 of 47) with videos related to

Sort By:
Pageof 5
Journal of Receptor Research|January 1, 1983
Model testing in radioligand/receptor interaction by Monte Carlo simulationE Bürgisser
Journal of Receptor Research|January 1, 1984
Methods for the determination of the specific radioactivity of radioligandsE Bürgisser
Helvetica Chimica Acta|April 21, 1976
One-step purification of bovine adrenal glucose-6-phosphate dehydrogenase by affinity chromatographyE Bürgisser, J L Fauchère
Journal of Receptor Research|January 1, 1983
Human lymphocytes as a model for beta-adrenergic receptors in clinical investigationR Landmann, E Bürgisser, F R Bühler
Molecular Pharmacology|May 1, 1981
Alternative explanation for the apparent "two-step" binding kinetics of high-affinity racemic antagonist radioligandsE Bürgisser, R J Lefkowitz, A DeLean
Journal of Cyclic Nucleotide and Protein Phosphorylation Research|January 1, 1985
Inhibition of [3H]Gpp(NH)p release from human platelet membranes by GDPL M Banta, F R Bühler, E Bürgisser
Molecular Pharmacology|December 1, 1985
Activation of human blood platelets by arginine-vasopressin. Role of bivalent cationsA Pletscher, P Erne, E Bürgisser, et al.
European Journal of Pharmacology|April 6, 1984
Inappropriate correction for radioactive decay in fully iodinated adrenergic radioligandsV M Doyle, F R Bühler, E Bürgisser
Naunyn-Schmiedeberg'S Archives of Pharmacology|April 1, 1984
Ca2+ as messenger of 5HT2-receptor stimulation in human blood plateletsH Affolter, P Erne, E Bürgisser, et al.
Hypertension (Dallas, Tex. : 1979)|August 1, 1986
Enhanced platelet cyclic AMP response to prostaglandin E1 in essential hypertensionT J Resink, E Bürgisser, F R Bühler
Pageof 5